Planned phase I trial to investigate the tolerability and pharmacokinetics of oral leuprorelin [leuprolide], formulated with DOR BioPharma's Lipid Polymer Micelle (LPM) technology.
Not yet recruiting
Phase of Trial: Phase I
Latest Information Update: 13 Feb 2008
At a glance
- Drugs Leuprorelin (Primary)
- Indications Prostate cancer
- Focus Adverse reactions
- 13 Feb 2008 New trial record.